dc.contributor.author |
Brito-de la Fuente, Edmundo |
|
dc.contributor.author |
Secouard, Sébastien |
|
dc.contributor.author |
Siegert, Nadja |
|
dc.contributor.author |
Payeras Perelló, Francina |
|
dc.contributor.author |
Gallegos, Crispulo |
|
dc.date.accessioned |
2020-01-24T08:57:28Z |
|
dc.identifier.uri |
http://hdl.handle.net/11201/150695 |
|
dc.description.abstract |
[eng] Ketosteril is an originator drug prescribed for nutrition therapy for patients with chronic kidney disease (CKD). Ketoanalogues (KAs) of amino acids are part of the active pharmaceutical ingredients in the Ketosteril film-coated tablets. |
|
dc.format |
application/pdf |
|
dc.relation.isformatof |
https://doi.org/10.14227/DT260219P30 |
|
dc.relation.ispartof |
Dissolution Technologies, 2019, vol. 26, num. 2, p. 30-38 |
|
dc.rights |
, 2019 |
|
dc.subject.classification |
66 - Enginyeria, tecnologia i indústria química. Metal·lúrgia |
|
dc.subject.other |
66 - Chemical technology. Chemical and related industries |
|
dc.title |
Determination of Dissolution Profile and Bioaccessibility of Ketosteril Using an Advanced Gastrointestinal in Vitro Model |
|
dc.type |
info:eu-repo/semantics/article |
|
dc.date.updated |
2020-01-24T08:57:28Z |
|
dc.date.embargoEndDate |
info:eu-repo/date/embargoEnd/2026-12-31 |
|
dc.embargo |
2026-12-31 |
|
dc.rights.accessRights |
info:eu-repo/semantics/embargoedAccess |
|
dc.identifier.doi |
https://doi.org/10.14227/DT260219P30 |
|